胺碘酮治疗老年人充血性心力衰竭并发室性心动过速疗效观察被引量：1

The Effect of Amiodarone on Heart Failure with Ventricular Tachycardia

下载PDF

导出

摘要目的观察静脉注射胺碘酮治疗老年人充血性心力衰竭并发室性心动过速的有效性及安全性.方法对38例老年人充血性心力衰竭并发室性心动过速患者给以静注胺碘酮治疗,并以治疗前后描记心电图,测定LVEF和LVDd.结果30例病人室速转为窦律,左室射血分数增加,9例发生不良反应,总有效率为78.9%,不良反应率23.7%,无心功能恶化.结论静脉注射胺碘酮治疗老年人充血性心力衰竭并发室速安全有效.转复律高,起效快. Obiective To investigate the effect and saty of amiodarone on aging congestive heart failure with ventricular tachycardia.Methods The 38 cases of heart failure with ventricular tachy cardia（vt）were given treatment by injection of Amiodarone.The electrocardiogram（ECT）,left ventricular ejection fraction（LVEF）,and left ventricular diastolic diameter（LVDd）were determined before and after treatmtnt.Results The rhythm of cardia in 30 heart failure patients with VT turned into sinus rhythm and LVEF increased.The efficiency was 78.9%,there was side effects in 9 patients,The ratio of side effect of amiodarone was 23.7%.Conclusion The treatment of amiodarone was safe and effective for heart faihure patients with VT.

作者杜海燕付东红陈建群

机构地区昆明市第一人民医院干疗科

出处《昆明医学院学报》 2009年第11期91-93,共3页 Journal of Kunming Medical College

关键词胺碘酮充血性心力衰竭室性心动过速 Amiodarone Congestive heart failure Ventricular tachycardia

分类号 R541.61 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献6

1高传玉,马业新,朱中玉,沈玉祥,李牧蔚,张静,张嘉莹.可达龙治疗顽固性室性心动过速和心室颤动的用药经验和临床疗效[J].实用诊断与治疗杂志,2005,19(4):235-236. 被引量：5
2HEGER J J,PRYSTOWSKY E N. Clinical use and phanmacology lxf Amjodarone [ J ]. Am Nclinmed, 1984 68(5 ) : 1340 - 1344.
3周淑娴,张旭明,伍卫,陈筱潮.胺碘酮对心力衰竭犬心室电生理特性的频率依赖性影响[J].中华心血管病杂志,1998,26(2):135-138. 被引量：12
4李萍,谢君,杨海波.可达龙在急性心肌梗塞后室性心律失常中的临床应用[J].中国误诊学杂志,2003,3(1):79-80. 被引量：3
5郭林妮,黄元铸,蒋文平,李庚山,陆再英,戚文航,任自文,吴宁,向晋涛,朱俊,方圻,高润霖.胺碘酮抗心律失常治疗应用指南[J].中国心脏起搏与心电生理杂志,2004,18(6):401-407. 被引量：392
6程祖亨,木胡牙提,马依彤,汤宝鹏,张爱伦.静脉应用胺碘酮转复初发心房颤动伴快心室反应疗效的观察[J].中华心律失常学杂志,2002,6(2):76-77. 被引量：15

二级参考文献21

1Auer J, Berent R, Eber B. Amiodarone in the prevention and treatment of arrhythmia[J]. Curr Opin Investig Drugs, 2002, 3(7):1037.
2Nolan J P, De Latorre F J, Steen P A, et al. Advanced life support drugs: do they really work[J]? Curr Opin Crit Care,2002, 8(3):212.
3Somberg J C, Bailin S J, Haffajee C I, et al. Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia [J]. Am J Cardiol, 2002,90(8) : 853.
4Yoshida H, Sugiyama A, Satoh Y, et al. Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class Ⅲ drug, sematilide, using a canine chronic atrioventricular block model[J]. Circ J, 2002, 66(8) :758.
5Strickberger S A, Hummel J D, Bartlett T G, et al.(AMIOVIRT Investigators). Amiodarone versus implantable cardioverter-defibrillator: randomized t rial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT [J]. J Am Coll Cardiol, 2003, 41 (10) : 1707.
6Middlekauff HR,Stevenson WG,Stevenson LW.Prognostic significance of atrial fibrillation in advanced heart failure:a study of 390 patients.Circulation,1991,84:40-45.
7Naccarelli GV,Wolbrette DL,Dell'Orfano JT,et al.Amiodarone:what have we learned from clinical trials? Clin Cardiol,2000,23:73-82.
8Sopher SM,Camm AT.Atrial fibrillation:maintenance of sinus rhythm versus rate control.Am J Cardial,1996,77:22A.
9Deedwania PC,Singh BN,Ellenbogen K,et al.Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation:observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT).The Department of Veterans Affairs CHF-STAT Investigators.Circulation,1998,98:2574-2579.
10Kreiss Y,Sidi Y,Gur H.Efficacy and safety of intravenous amiodarone in recent onset atrial fibrillation:experience in patients admitted to a general internal medicine department.Postgrad Med J,1999,75:278- 281.